In 2022, the global Hereditary Testing Market, specifically hereditary testing, reached a size of USD 11.1 Billion. According to the most recent report from Reports and Data, it is projected to maintain a revenue Compound Annual Growth Rate (CAGR) of 11% throughout the forecast period.
The rise in the occurrence of genetic disorders like cystic fibrosis, Huntington’s disease, and sickle cell anemia on a global scale has created a demand for hereditary testing. Moreover, the prevalence of cancer is increasing, and genetic testing has become a valuable tool for early detection and improved medical management. According to the World Health Organization (WHO), cancer is anticipated to be the second leading cause of death worldwide in 2020, responsible for 10 million fatalities. Hereditary testing can identify genetic irregularities that elevate the risk of cancer, permitting early intervention and enhancing treatment outcomes.
The growing recognition of personalized therapy has driven an increased need for hereditary testing. By leveraging genetic data, treatment strategies can be customized to match the unique genetic profiles of individual patients, thereby boosting treatment effectiveness and minimizing adverse effects. Consequently, the popularity of hereditary testing for gathering genetic data to enable personalized medication is on the rise.
Access Free sample PDF Copy of the Report @
Technological advancements have also yielded more precise and efficient genetic testing methods. For example, Next-Generation Sequencing (NGS) permits the simultaneous analysis of multiple genes, causing a revolution in the field of genetic testing. This has made testing more cost-effective and accessible to the general population while simultaneously enhancing accuracy and reducing turnaround time.
Key players in the Hereditary Testing Market:
- Abbott Laboratories
- Agilent Technologies, Inc.
- BGI Genomics Co., Ltd.
- F. Hoffmann-La Roche Ltd.
- Genomic Health, Inc.
- Myriad Genetics, Inc.
- Qiagen N.V.
- Invitae Corporation
- PerkinElmer, Inc.
- Thermo Fisher Scientific Inc.
Some Key Highlights in the Report:
- In 2022, the largest portion of revenue in the global hereditary testing market was captured by the predictive testing segment. This was primarily due to the increasing adoption of personalized medicine, a heightened emphasis on early disease detection, and greater awareness of genetic diseases and disorders. Predictive testing, a type of genetic test that does not diagnose a condition but uses DNA analysis to estimate the likelihood of a hereditary disease or condition manifesting.
- During the forecast period, the diagnostic labs segment is expected to exhibit the most rapid revenue growth rate in the global hereditary testing market. This can be attributed to the rising prevalence of chronic illnesses, the demand for precise and timely diagnoses, and the utilization of Point-Of-Care (PoC) testing. Diagnostic laboratories conduct a variety of tests, including clinical chemistry, microbiology, hematology, and immunoassay testing.
- Throughout the forecast period, the North American market maintained the largest share of revenue in the global hereditary testing market. This can be attributed to the implementation of supportive policies for hereditary testing in the region. Additionally, the increasing prevalence of genetic disorders such as cancer, Cardiovascular Diseases (CVDs), and neurological disorders, coupled with substantial healthcare expenditure and investments in research and development (R&D), are expected to drive revenue growth in the North American market.
- In contrast, the European market is anticipated to witness the swiftest revenue growth rate in the global hereditary testing market during the forecast period. This growth is linked to the expanding presence of various diagnostic laboratories and heightened awareness of genetic disorders in the region. Furthermore, increasing rates of CVD and cancer, the presence of significant companies, and the implementation of government initiatives to promote hereditary testing are also expected to fuel revenue growth in the European market.
Get in detailed Research Study @ https://www.reportsanddata.com/report-detail/hereditary-testing-market
For the purpose of this report, Reports and Data has segmented the global hereditary testing market on the basis of Test Type Outlook, Technology Outlook, End-use Outlook, and Regional Outlook:
Test Type Outlook (Revenue, USD Billion; 2022 – 2032)
- Predictive Testing
- Carrier Testing
- Prenatal and Newborn Testing
- Diagnostic Testing
Technology Outlook (Revenue, USD Billion; 2022 – 2032)
- Molecular Diagnostics
- Next-Generation Sequencing (NGS)
- Sanger Sequencing
- Polymerase Chain Reaction
End-use Outlook (Revenue, USD Billion; 2022 – 2032)
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Laboratories
Download Summary @ https://www.reportsanddata.com/download-summary-form/6375
Regional Outlook (Revenue, USD Billion; 2022-2032)
- North America
- Rest of Europe
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/6375
Some points on how the report benefits stakeholders:
- The reports include historical (2020–2021) and forecast (2022–2032) data points, revenues, and CAGR in table, figure, and chart formats, with detailed and qualitative, supporting written information for each.
- Revenue break-up is provided for each segment in these formats for global, regional, and for each country in the respective region for each year between 2019 and 2030.
- The report contains insights regarding growth drivers, restraints, opportunities, trends, company profiles, strategic developments, expansion details, product launches, and various other aspects related to the market.
- The report contains data and information on customers, competitors, vendors/distributors, and other players and in the global marketplace.
- Market research analysis is vital for all crucial business strategies and can aid in numerous ways and to provide a clearer understanding about strategies being deployed by competitors, product launches, competitive analysis, technological advancements and various other factors that enhance sales of a firm or perhaps provide insights to focus on merger and acquisition as a strategy or enter into strategic agreements or joint ventures etc.
- The report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, geographical reach, market footprint, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.
Explore Latest Trending Research Reports By Reports and Data’s
Influenza Diagnostics Market, By Product Type [Rapid Influenza Diagnostic Tests (RIDT), Reverse Transcriptase Polymerase Chain Reaction (RT-PCR), Cell Culture, Immunofluorescence, and Others], By End-use (Hospitals, Clinical Laboratories, Research Laboratories, and Others), and By Region Forecast to 2032
Blockchain in Healthcare Market by Type (Public, Private, Hybrid), Application (Clinical Data Exchange & Interoperability, Claims Adjudication & Billing Management, Drug Supply Chain Management, Clinical Trials, Others), End-use (Pharmaceutical Companies, Healthcare Providers, Healthcare Payers), By Region Forecast to 2032
Hospital Equipment and Supplies Market, By Product Type (Diagnostic Equipment, Patient Monitoring Equipment, Operating Room Equipment, Mobility Aids and Transportation Equipment, Sterilization Equipment, and Others), By End-use (Hospitals, Clinics, and Others), and By Region Forecast to 2032
Paper Diagnostics Market, By Product Type (Lateral Flow Assays, Paper-based Microfluidics, Dipsticks, and Others), By Application (Clinical Diagnostics, Food Quality Testing, Environmental Monitoring, and Others), and By Region Forecast to 2032
Silver Wound Dressing Market, By Product Type (Foam Dressings, Hydrocolloid Dressings, Alginate Dressings, Film Dressings, and Others), By Application (Chronic Wounds, Acute Wounds, and Surgical Wounds), and By Region Forecast to 2032
Extremity Tissue Expanders Market, By Type (Upper Extremity and Lower Extremity), By Application (Breast Reconstruction, Skin and Soft Tissue Reconstruction, and Others), and By Region Forecast to 2032
Casting and Splinting Market By Product Type (Plaster, Fiberglass, Polyurethane, Others), By Application (Trauma & Orthopedic, Sports Injury, Others), By Region Forecast to 2032
Multiparameter Patient Monitoring Systems Market, By Type (Portable and Fixed), By Acuity Level (High-acuity, Mid-acuity, and Low-acuity), By End-Use [Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)], and By Region Forecast to 2032
Regenerative Medicine Market, By Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Others), By Application (Orthopedic, Dermatology, Cardiovascular, Neurology, and Others), and By Region Forecast to 2032
Microfluidics Market, By Product Type (Microfluidic Chips, Microfluidic Sensors, Microfluidic Pumps, and Others), By Application [Clinical and Veterinary Diagnostics, Point-of-Care Testing (POCT), Drug Delivery, and Others], and By Region Forecast to 2032
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Read Latest Press Release @ https://www.reportsanddata.com/press-release/global-hereditary-testing-market